0.5125
Schlusskurs vom Vortag:
$0.4929
Offen:
$0.505
24-Stunden-Volumen:
296.70K
Relative Volume:
1.60
Marktkapitalisierung:
$2.17M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.0514
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
+0.83%
1M Leistung:
-47.70%
6M Leistung:
-77.22%
1J Leistung:
-90.60%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Vergleichen Sie SXTP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SXTP
60 Degrees Pharmaceuticals Inc
|
0.5125 | 2.09M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
Published on: 2026-01-09 01:34:54 - ulpravda.ru
Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoptionEarnings Overview Report & High Yield Equity Trading Tips - ulpravda.ru
Is 60 Degrees Pharmaceuticals Inc. stock a top momentum playJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - ulpravda.ru
Published on: 2026-01-08 21:47:54 - ulpravda.ru
Shorts Report: Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoption2025 Earnings Surprises & Real-Time Stock Price Movement Reports - ulpravda.ru
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock deliver long term returnsJuly 2025 Short Interest & Safe Capital Growth Tips - ulpravda.ru
Published on: 2026-01-08 20:08:34 - ulpravda.ru
Will 60 Degrees Pharmaceuticals Inc. stock deliver consistent dividendsWeekly Trade Report & Long Hold Capital Preservation Tips - ulpravda.ru
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to analystsMarket Performance Recap & Fast Entry and Exit Trade Plans - ulpravda.ru
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index
60 Degrees Pharma outlines growth strategy in investor webinar - TipRanks
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryDividend Hike & Verified Entry Point Detection - ulpravda.ru
60 Degrees Pharmaceuticals, Inc. Updates on Clinical Development and Regulatory Strategy - TradingView — Track All Markets
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to dividend seekers2026 world cup usa national team final star players transition play group prediction tactical review - ulpravda.ru
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Jackson Sun
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Sees Large Growth in Short Interest - Defense World
60 Degrees Pharmaceuticals, Inc. Confirms Continuation of B-FREE Study to Assess ARAKODA® for Chronic Babesiosis Treatment - Quiver Quantitative
60 Degrees Pharmaceuticals Announces Detection of Babesia - GlobeNewswire
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State - Sahm
Tick-borne parasite found in 1 in 4 people with chronic fatigue in new study - Stock Titan
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Coloradoan
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):